Expert Zahra Mahmoudjafari on Turning Innovation Into Implementation in Cell and Gene Therapy Programs

Cell and gene therapies (CGTs), including chimeric antigen receptor (CAR) T-cell therapies, tumor-infiltrating lymphocytes, and gene therapies, represent one of the most innovative and disruptive advances in modern medicine. They offer potentially curative, one-time treatments that fundamentally redefine how clinicians approach serious and previously incurable diseases.